Trending Now
Incyte (NASDAQ:INCY) Reports Exceptional Performance In Q3 Thanks To Jakavi® Sales
Incyte (NASDAQ:INCY) has announced Q3 financial results and provided a status update on its development portfolio.
The company reported a 16% YoY growth in total...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Virpax Pharmaceutical Inc. (NASDAQ: VRPX) Enters Supply and Manufacturing Agreement For...
Virpax Pharmaceutical Inc. (NASDAQ: VRPX) and Seqens have announced the signing of a commercial supply and manufacturing agreement for MMS019.
Virpax and Seqens enter a...
MAKE IT MODERN
LATEST REVIEWS
Adaptive Biotechnologies Corp (NASDAQ: ADPT) Appoints a New Chief Financial Officer
Adaptive Biotechnologies Corp (NASDAQ: ADPT) has appointed a new chief financial officer (CFO). Tycho Peterson, who will fill the role, has decades of experience...
MAKE IT MODERN
PERFORMANCE TRAINING
Agile Therapeutics (NASDAQ:AGRX) goes parabolic on positive sentiment and continued run
Agile Therapeutics (NASDAQ:AGRX) is expecting a FDA approval for its contraceptive patch, Twirla. However, right now the technical chart looks impressive. Agile...
Qiagen NV (NYSE:QGEN) And Inovio Pharmaceuticals Inc (NASDAQ:INO) In A Master Collaboration To Develop...
Qiagen NV (NYSE:QGEN) and Inovio Pharmaceuticals Inc (NASDAQ:INO) have moved into a new master collaboration agreement. The two companies will make joint efforts to...
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) Finalizes Enrolment In Its Second Phase Etrasimoid ADVISE Trial For...
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) has announced the completion of enrolment in its Phase 2b ADVISE study for the evaluation of etrasimod as a next-generation...
Semiconductor Shares Surge Amid AI-Driven Boom (AMD,NVDA)
Semiconductor stocks are soaring, and it seems artificial intelligence is a major catalyst. With Nvidia leading the charge due to its AI...
The US FDA Grants Fast Track Designation To IND – LB1148 Of Palisade Bio...
The US FDA granted fast track designation to Palisade Bio Inc (NASDAQ:PALI)’s LB1148 to treat adhesions following pelvic or abdominal surgery.
MAKE IT MODERN
